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Abstract
Objective: To investigate the importance of the phosphorylation of Ser16 and Thr17 sites of phospholamban (PLN) on intracellular Ca2+ 
(Ca;+) handling and contractile recovery of the stunned myocardium.
Methods: Ca2 (Rhod-2, pulsed local-field fluorescence microscopy) and contractility (isovolumic left ventricular developed pressure, 
LVDP) were simultaneously measured in Langendorff perfused hearts from transgenic mice expressing either intact PLN (PLN-WT) or 
PLN with both phosphorylation sites mutated to Ala (PLN-DM), subjected to 12 min of global ischemia followed by a reperfusion period 
of 30 min.
Results: Pre-ischemic values of Caj+ and LVDP were similar in both groups. In PLN-WT, a transient increase in Thr17 phosphorylation at 
early reperfusion preceded a recovery of Ca2+ transient amplitude, virtually completed by the end of reperfusion. LVDP at 30 min reperfusion 
was 67.9 ±7.6% of pre-ischemic values, n = 14. In contrast, in PLN-DM, there was a poor recovery of Ca2 transient amplitude and LVDP was 
significantly lower (28.3 ±6.7%, » = 11, 30 min reperfusion) than in PLN-WT hearts. Although myofilament Ca2+ responsiveness and 
troponin I (Tnl) degradation did not differ between groups, the episodes of mechanical altemans, typical of Caj+ overload, were significantly 
prolonged in PLN-DM vs. PLN-WT hearts.
Conclusions: PLN phosphorylation appears to be crucial for the mechanical and Cai recovery during stunning and protective against the 
mechanical abnormalities typical of Ca© overload. The importance of PLN phosphorylation would primarily reside in the Thr17 residue, 
which is phosphorylated during the critical early phase of reperfusion. Our results emphasize that, although ablation of PLN phosphorylation 
does not affect basal contractility, it does alter Ca2+ handling and mechanical performance under stress situations.
© 2006 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
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1. Introduction
Myocardial stunning describes the sustained contractile 
dysfunction that follows a brief ischemic insult, clinically
manifested as sluggish recovery of pump function after 
revascularization. This post-ischemic dysfunction occurs 
in the absence of irreversible damage and despite 
restoration of normal coronary flow, and evolves towards 
complete recovery within hours, days or weeks [1,2]. 
Substantial evidence, mainly stemming from experiments 
in rodents, supports the idea that Ca2+ overload during 
reflow triggers myofilament dysfunction, which effectively 
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uncouples excitation from contraction so that, at any 
given Ca2+ level, the force generated by the myocardium 
is diminished [2]. In this sense, myocardial stunning can 
be considered as an alteration of myofilament function. In 
spite of the considerable evidence accumulated in favor of 
a decrease in Ca2+ myofilament responsiveness as the 
cause of stunning in rodents, there is also evidence 
indicating that Ca2+-handling proteins may also play a 
role during stunning in this species. Although Ca2+ was 
found to be normal at the end of reperfusion [3,4], 
sarcoplasmic reticulum (SR) function has been shown to 
be altered in stunned rat hearts [5]. Moreover, we have 
previously shown that the level of phosphorylation of 
phospholamban (PLN), the main regulatory protein of SR 
Ca2+ pump, increased during both ischemia and reperfu­
sion and that this increase appears to contribute to the 
mechanical recovery of the stunned heart [6,7]. Further 
experiments in transgenic mice, in which PLN-phosphor- 
ylation sites were alternatively replaced by the non- 
phosphorylatable residue, Ala, indicated that both PLN 
sites, Ser16 (phosphorylated by PKA) and Thr17 (phos­
phorylated by CaMKII), seem to be necessary for the 
mechanical recovery [7], suggesting that Ca2+ handling 
proteins might be involved in the recovery of the stunned 
rodent heart. Taken together, these results allowed us to 
hypothesize that the presence of PLN phosphorylation 
sites would help to limit Ca2+ overload and ameliorate 
Ca2+ handling. Two corollary hypotheses are that the 
decrease in Ca2+ myofilament responsiveness and the 
propensity to mechanical alterations and arrhythmias, 
typical of stunning [8,9], would occur to a lesser extent 
in the presence than in the absence of PLN phosphory­
lation sites. To test these hypotheses, we performed 
experiments in perfused hearts from mice, in which both 
PLN phosphorylation sites were mutated to Ala (PLN- 
DM). In these hearts, mechanical parameters were 
measured during ischemia and reperfusion simultaneously 
with intracellular Ca2+, assessed by pulsed local-field 
fluorescence microscopy [10]. 2*
2. Methods
2.1. Animals
Experiments were performed in phospholamban (PLN)
transgenic mice (28-32 g body weight) expressing either
wild type PLN (PLN-WT) or a mutant PLN in which
both phosphorylation residues (Ser16 and Thr17) were
replaced by Ala (PLN-DM) into the PLN null background
(SvJ129/CFl). The transgenic mouse models were devel­
oped as previously described [11,12]. Animals used in
this study were maintained in accordance with the
National Institutes of Health Guide for the Care and
Use of Laboratory Animals (NIH Pub. No. 85-23,
Revised 1996).
2.2. Langendorff isolated heart preparations. Mechanical 
and intracellular Ca2+ measurements
Isolated mouse hearts (wet weight 0.20-0.30 g) were 
perfused according to the Langendorff technique at 
constant temperature (37 °C) and perfusion pressure (80 
mm Hg). Hearts were paced at 5 Hz. The composition of 
the Tyrode solution was (in mM): 140 NaCI, 5.4 KCl, 2 
CaCI2, 0.33 KH2PO4, 1 MgCl2, 10 glucose, and 10 
HEPES; pH 7.4; equilibrated with 100% O2. Mechanical 
activity of the hearts was assessed by passing into the left 
ventricle a latex balloon connected to a pressure transducer 
(Motorola MPX5050, Co., USA). The balloon was filled 
with aqueous solution to achieve a left ventricular end- 
diastolic pressure (LVEDP) of approximately 18 mm Hg to 
compare with previous results [7]. Contractile performance 
of the left ventricle was evaluated by the developed 
pressure (LVDP) and relaxation was assessed by half 
relaxation time (Uo)-
Intracellular Ca2+ was estimated by loading the hearts 
with Rhod-2 (Molecular Probes, Eugene, OR, USA), as 
previously described [10]. The hearts were perfused with 
dye-containing Tyrode solution for a period that ranged 
between 15 and 20 min at 2 Hz and at room temperature. 
After loading, the temperature was increased to 37 °C. 
Pulsed light from a Nd-Yag laser (532 nm) was focused 
into a multimode optical fiber (400 pm) for transmission 
of the exciting light to the heart surface. Light pulses of 
short duration allow the use of high peak power, 
increasing the signal to noise ratio. Because the fluores­
cence lifetime (t = 5.6 ns) exceeds the duration of the 
exciting light pulse, the amount of photobleaching is 
considerably reduced. Emitted light from the loaded 
fluorophore was carried back through the same fiber 
optic, filtered with a 590 nm Longpass Glass Color Filter 
(Edmund Scientific USA) and focused on an avalanche 
photodiode (EG & G, Canada) connected to an integrat­
ing current-to-voltage converter, controlled by a PIC 
microcontroller. The fiber optic was positioned lateral to 
the left ventricle, touching the epicardium. Motion 
artifacts were reduced by inserting one end of the fiber 
optic, into a borosilicate patch-clamp pipette, and apply­
ing negative pressure to hold the pipette to the tissue 
surface. Signals were digitized (PCI 6110, National 
Instruments, TX, USA) at a sampling frequency of 500 
Hz, a bandwidth of 125 kHz and the photocurrent was 
evaluated by digital integration. Left ventricular pressure 
and temperature were acquired with a different analog-to- 
digital converter (PCI 6014, National Instruments, TX), at 
a sampling frequency of 50 kHz. Both acquisition 
systems were controlled by an Athlon MP PC, running 
a custom-designed, G-based software program (LabVIEW, 
National Instruments, TX, USA).
Because the amplitude of Rhod-2 fluorescence transient 
depends on free [Ca2+], the estimation of its value allows 
to continuously monitor the intracellular [Ca2+] changes 
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over time. Ca2+ performance was evaluated by the 
diastolic levels of fluorescence compared to pre-ischemic 
values, and the amplitude of Ca2+ transients, expressed as 
ratio between emitted (F-Fo) and basal (Fo) fluorescence 
(AF/F0).
2.3. Experimental protocol
After stabilization (pre-ischemia), hearts were subjected 
to 12 min normothermic global ischemia (interruption of 
the coronary flow) and coronary perfusion was then 
restored for 30 min (reperfusion). At the end of the 
experimental period, hearts were freeze-clamped and 
stored at —80 °C until biochemical assays. Myocardial 
contractility and Ca2+ transients were not altered in control 
experiments (77=4) in which all conditions of the 
ischemia/reperfusion protocol [dye loading, shutter open­
ings at the time of acquisition], except for the interruption 
of coronary flow, were reproduced.
2.4. Preparation of mouse heart homogenates
The pulverized ventricular tissue from mouse hearts 
was homogenized as previously described [7]. The 
homogenate was centrifuged at 16,000 xg for 20 min. 
Protein in the supernatant was measured by the method of 
Bradford.
2.5. Electrophoresis and Western blot analysis
25 and 15 pg of mouse homogenate proteins were 
electrophoresed per gel lane for PLN and Tnl, respectively, 
in 12% SDS-polyacrylamide gels as previously described 
[6]. Proteins were transferred to PVDF membranes (Immo- 
bilon-P, Millipore) and immunoblotted with antibodies 
raised against a PLN peptide (residues 9—19) phosphory­
lated at Ser16 or at Thr17 (1:5000) (Badrilla, UK) and anti- 
Tnl (1:2000) (mAb 81-7, Spectral Diagnostics). Signals 
were visualized by peroxidase-conjugated antibodies using
Ischemia Reperfusion
PSer16-PLN
PThr17-PLN
1 pM KN-93 +
Prel Rep 1 min
Fig. 1. Time course of PLN site-specific phosphorylation during ischemia and reperfusion in mice. Effect of KN-93. (A) Homogenates from mouse hearts 
freeze-clamped at the end of the pre-ischemic period (Prel) and at different times during ischemia (I) and reperfusion (R), were resolved in SDS-polyacrylamide 
gel electrophoresis. Proteins were blotted and assayed with anti PSer16-PLN and PThr17-PLN antibodies (upper panel). Overall results (n =4-20) are expressed 
as percentage of the phosphorylation of PLN sites induced by 30 nM isoproterenol (Iso) in non-ischemic hearts. #P <0.05 with respect to Prel. (B) 
Representative inmunoblots showing that reperfusion-induced increase in Thr17 phosphorylation in the absence of KN-93 (Rep 1 min, —) was abolished by 
CaMKII inhibition with KN-93 (Rep 1 min , +).
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a chemiluminescence detection kit (ECL, Amersham). The 
signal intensity of the bands was quantified using Scion 
Image software. PLN site-specific phosphorylation was 
expressed as percentage of Ser16 and Thr17 phosphorylation 
induced by 30 nM isoproterenol in non-ischemic-reperfused 
hearts. Tnl degradation was expressed as a % of the total 
immunoreactivity: i.e. density of the degradation products/ 
Xfdensity of intact band + density of degradation 
products) x 100.
2.6. Statistics
Data are expressed as means!S.E. Statistical signifi­
cance was determined by Student’s t-test for impaired
A
PLN-WT
Ischemia
2 mm
Ischemia
B
PLN-DM
2 min
Pre-lschemia 30 min Reperfusion
PLN-DM
50 ms
Fig. 2. Representative records of left ventricular pressure and intracellular Ca2+ transients of hearts from PLN-WT and PLN-DM mice during ischemia and 
reperfusion. (A) Continuous records of left ventricular pressure of PLN-WT and PLN-DM hearts. Ischemia reduced contractility to non-detectable levels and 
then contractility recovered during reperfusion. This recovery was lower is PLN-DM than in PLN-WT. (B) Ca2+ transients obtained before ischemia (pre­
ischemia) and after 30 min of reperfusion. At the end of reperfusion, there is a decrease in the amplitude of the Ca2+ transient and an increase in diastolic 
Ca2+ in PLN-DM hearts with respect to pre-ischemic values and to the corresponding values of hearts from PLN-WT animals. Scale on vertical axis 
represents arbitrary units (AU) of Rhod-2 fluorescence, expressed as ratio between emitted (F-Fo) and basal (Fo) fluorescence (AF/F0).
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observations. A P value <0.05 was considered statistically 
significant.
3. Results
Fig. 1A shows overall results depicting the time course of 
phosphorylation of Ser16 and Thr17 of PLN in hearts from 
WT mice during ischemia and reperfusion. The phosphor­
ylation of both sites decreased by the end of ischemia. 
Whereas phosphorylation of Ser16 remained at basal levels 
all along the reperfusion period, phosphorylation of Thr17 
transiently increased at the beginning of reperfusion (1 and 
3 min), and then returned to basal values, in agreement with 
previous findings [7]. Perfusion with 1 |i\1 of the CaMKII 
inhibitor, KN-93, administered 10 min previous to the
ischemia/reperfusion protocol, abolished the reperfusion- 
induced Thr17-phosphorylation (Fig. IB). These results 
confirmed the participation of CaMKII in the phosphoryla­
tion of Thr17 at the beginning of reperfusion, in agreement 
with our previous findings in the rat heart [6,7]. To 
investigate whether the status of phosphorylation of PLN 
residues influenced Ca2+ recovery in the stunned heart, we 
simultaneously evaluated the mechanical and Caf changes 
of hearts from PLN-WT and PLN-DM mice. Fig. 2A 
illustrates continuous recordings of left ventricular devel­
oped pressure (LVDP) at baseline and during ischemia and 
reperfusion, in hearts from PLN-WT and PLN-DM mice. 
Fig. 2B shows representative Ca2 transients, before 
ischemia and after 30 min of reperfusion. Basal contractility 
and Ca2 showed no differences between PLN-WT and 
PLN-DM mice, in agreement with previous findings in 
Fig. 3. Time course of left ventricular function of hearts from PLN-WT and PLN-DM mice during ischemia and reperfusion. (A) Overall results of the time 
course of left ventricular developed pressure (LVDP). LVDP decreased to virtually non-detectable levels after cessation of flow. Upon reperfusion contractility 
recovered, reaching 67.9 ±7.6% (PLN-WT) and 28.3 ±6.7% (PLN-DM) of pre-ischemic values, after 30 min of reperfusion. Absolute pre-ischemic values for 
LVDP for PLN-WT and PLN-DM were: 70.9+12.6 and 78.4 ±11.1 mm Hg, respectively. (B) Overall results of the time course of end diastolic pressure 
(LVEDP). LVEDP decreased immediately after cessation of flow and then increased slowly in PLN-WT and more abruptly in PLN-DM hearts during ischemia. 
Upon reperfusion, LVEDP increased dramatically in both groups, remaining at this high level throughout reperfusion. LVEDP levels were significantly higher 
in PLN-DM vs. PLN-WT hearts, all along reperfusion. Points represent mean± S.E.M. of data from 13 to 16 hearts (for WT mice) and 11 hearts (for DM mice). 
*P<0.05 with respect to PLN-WT hearts.
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isolated myocytes [13]. When coronary flow was interrup­
ted, LVDP fall abruptly in hearts of both groups of mice, 
remaining at virtually non-detectable levels during the 
ischemic period. Upon reperfusion, LVDP recovered grad­
ually, without reaching pre-ischemic values. In PLN-DM 
hearts, the recovery of contractility was lower than in PLN- 
WT hearts and it was associated with a markedly reduced 
Ca2+ transient amplitude with respect to pre-ischemic levels. 
In contrast, in PLN-WT mice, Ca2+ transient amplitude 
recovered to values close to pre-ischemic levels at 30 min of 
reperfusion. Both the contracture developed during ischemia 
and the elevation of diastolic pressure in early reperfusion 
(“hypercontracture”, [14]) were higher in PLN-DM than in 
PLN-WT mice. At the same time, diastolic pressure tended 
to recover to pre-ischemic levels in PLN-WT mice, while it 
remained markedly elevated in PLN-DM mice throughout 
reperfusion. These experiments, performed at constant
perfusion pressure, showed a similar mechanical pattern to 
that observed in previous experiments performed at constant 
coronary flow in PLN-WT and transgenic mice with either 
one of both phosphorylation sites mutated to Ala [7]. 
Diastolic Ca2+ recovered towards pre-ischemic levels by the 
end of reperfusion in PLN-WT mice, while it remained 
significantly increased in PLN-DM mice. Figs. 3 and 4 
illustrate the overall results of the mechanical and intracel­
lular Ca2+ measurements. The average data showed that 
after 30 min of reperfusion, contractility (LVDP) recovered 
to 67.9 + 7.6% of pre-ischemic values in PLN-WT hearts, 
while in PLN-DM hearts the recovery was significantly 
lower (28.3 ±6.7%) (Fig. 3A). Similar results were obtained 
with +dP/dt (data not shown). Moreover, the increase in 
LVEDP at the end of ischemia and throughout reperfusion 
was significantly higher in PLN-DM mice vs. PLN-WT 
mice (Fig. 3B) and the time to the onset of ischemic 
Reperfusion time (min)
Fig. 4. Time course of intracellular Ca2+ and Ca2+ transient amplitude during reperfusion. (A) Systolic Ca2+ increased upon reperfusion and then remained near 
pre-ischemic levels all along the reperfusion in PLN-WT hearts and slightly above pre-ischemic values in PLN-DM hearts. In both, PLN-WT and PLN-DM 
hearts, diastolic Ca2+ increased immediately after reperfusion. However, it recovered to pre-ischemic values in PLN-WT hearts, but it remains at high levels in 
PLN-DM hearts. (B) Overall results of the time course of the recovery of the Ca2+ transient amplitude (shadow area in A), after the ischemic insult. Ca2+ 
transient amplitude reached 84.6±6.7% (PLN-WT) and 50.2 ±8.0% (PLN-DM) of pre-ischemic values at 30 min of reperfusion. Intracellular Ca2+ and Ca2+ 
amplitude (AF/F0) were expressed as percentage of pre-ischemic values. Points represent mean±S.E.M. of data from 13 to 16 hearts (for PLN-WT mice) and 
17 to 18 hearts (for PLN-DM mice). # indicates P <0.05 with respect to pre-ischemic values. * indicates that diastolic Ca2+ is significantly (P <0.05) different 
between PLN-DM and PLN-WT.
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contracture (an increase in LVEDP of 4 mm Hg from 
baseline, [15]), was significantly shorter in PLN-DM than in 
PLN-WT mice (542.7 + 66.3 vs. 686.6121.0 s, respective­
ly). Fig. 4A and B shows the time course of diastolic, 
systolic and Ca2+ transient amplitude after the ischemic 
insult. In PLN-WT hearts, after an initial Ca2+ overshoot at 
the beginning of reperfusion, diastolic Ca2+ returned to pre- 
ischemic levels within 10-15 minutes. Ca2+ transient 
amplitude recovered towards pre-ischemic levels during 
reperfusion, attaining values only slightly, although signif­
icantly, lower than pre-ischemic values at 30 min of 
reperfusion. Thus, the contractile decrease of these hearts 
should be primarily attributed to a decrease in myofibrillar 
Ca2+ responsiveness, as previously described in rat, guinea 
pig and ferret hearts [3,4,16]. In contrast, in PLN-DM 
hearts, diastolic Ca2+ remained at high levels during 
reperfusion and Ca2+ transient amplitude was markedly 
decreased. This decrease may explain the greater impair­
ment of contractility in PLN-DM hearts with respect to 
PLN-WT hearts, following the ischemia/reperfusion period. 
In addition, the mishandling of Ca2+ and the persistency of 
Ca2 overload in PLN-DM hearts could produce a more 
important alteration in the myofilament Ca2+ responsive­
ness, which would also contribute to the contractile 
dysfunction observed in these mice. For the same reason, 
the propensity towards mechanical alterations and arrhyth­
mias exhibited by the stunned heart [8,9] may also be 
increased in PLN-DM hearts. To investigate these issues, we 
studied the relationship between developed pressure and 
Ca2+ transient amplitude, as an estimation of myofilament 
Ca2+ responsiveness, and we evaluated the integrity of Tnl. 
Tnl was examined because, although somewhat controver­
sial [17], a Ca2+-calpain-dependent Tnl degradation has 
been proposed as the molecular mechanism of myocardial 
stunning in rodents [2]. Fig. 5A depicts the relationship 
between LVDP and Ca2+ transient normalized to pre-
Fig. 5. Ca2+ transient and developed pressure relationship in PLN-WT and PLN-DM mice during reperfusion and kinetics of the developed pressure and Ca2+ 
transient at 30 min of reperfusion. (A) Relationship between developed pressure (LVDP) and Ca2+ transient amplitude expressed as % of pre-ischemic values, 
during reperfusion in PLN-WT and PLN-DM mice. (B) ¿50 of the developed pressure and the Ca2+ transient decay after 30 min of reperfusion expressed as 
differences from pre-ischemic values. Only in PLN-WT hearts, the decrease in ¿50 of the pressure decay was significant with respect to pre-ischemic values 
(relaxant effect). ¿50 of the Ca2+ transient decay was prolonged in both mice. Absolute values of ¿50 were: 37.4±2.1 and 37.7±2.5 ms (for pressure) and 
44.8+1.8 and 41.3±1.4 ms (for Ca2+ transient) for PLN-WT and PLN-DM, respectively. # indicates P<0.05 with respect to pre-ischemic values. (C) Left 
panel. Typical immunoblot showing Tnl degradation in two PLN-WT and three PLN-DM hearts, each one in duplicate. Right panel. Overall results of Tnl 
degradation, expressed as % of total Tnl, in PLN-WT and PLN-DM hearts. No significant difference could be detected between both groups.
c
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200 ms
Arrythmias Altemans
Fig. 6. Mechanical alterations after reperfusion. (A) Typical alterations in the mechanical behavior during reperfusion in PLN-DM hearts. (B) Average duration 
of the arrhythmic and mechanical altemans episodes in PLN-WT and PLN-DM hearts. * indicates P<0.05 with respect to PLN-WT.
ischemic values, at each data point throughout the last 25 
min of reperfusion. Points for both PLN-WT and PLN-DM 
mice followed a similar relationship within the range of 
LVDP and Ca2 transient common to both groups. Fig. 5B 
illustrates the behavior of t50 of LVDP and Ca2 transient 
decay in both groups of hearts, expressed as differences with 
respect to pre-ischemic values (A ms). In PLN-WT, there 
was a significant decrease in the t50 of LVDP associated 
with a significant increase in the t50 of the underlying Ca2 
transient, consistent with a decrease in Ca2 myofilament 
responsiveness. PLN-DM hearts exhibit a similar behavior, 
although the decrease in t50 °f LVDP did not attain 
significant levels. This lack of significance observed in the 
PLN-DM hearts is possible due to the fact that the decrease 
in Ca2 myofilament responsiveness may be masked by the 
superimposed abnormalities in Ca2 handling of these 
hearts. Fig. 5C shows an immunoblot and the overall results 
depicting Tnl degradation in both groups of hearts after 30 
min of reperfusion. The results failed to detect any 
significant difference in the degradation of Tnl between 
PLN-DM and PLN-WT hearts. Additional experiments 
showed however, that Tnl degradation after 12/30 min 
ischemia/reperfusion in mice with native PLN did not differ, 
when compared with hearts perfused under control con­
ditions for the same time period, in agreement with some 
previous findings [17].
Previous studies indicated that the ischemic/reperfusion 
insult produced mechanical alterations, like mechanical 
altemans, aftercontractions and cardiac arrhythmias [8,9]. 
In the present experiments, aftercontractions were not 
observed in any of the two groups. However, both groups 
presented episodes of mechanical altemans and cardiac 
arrhythmias (ventricular tachycardia, VT) at different times 
during reperfusion. A typical example of an episode of 
mechanical altemans in a PLN-DM heart is shown in Fig. 
6A. The incidence of the VT was similar for both groups of 
hearts, i.e. 11 out of 15 hearts from PLN-WT animals and 13 
out of 18 hearts from PLN-DM. The length of these 
arrhythmic periods was also similar for both groups (Fig.
6B). Moreover, whereas the incidence of episodes of 
mechanical altemans was similar in both groups of hearts, 
the duration of these episodes was significantly higher in 
PLN-DM hearts (Fig. 6B).
4. Discussion
The main finding of the present study is that the presence 
of PLN phosphorylation sites enhances the recovery of 
intracellular Ca2 and contractility in the stunned mouse 
heart. We showed that in transgenic mice, that expressed 
intact PLN (PLN-WT), reperfusion produced a significant 
and transient increase in Thr17 phosphorylation, which 
preceded a rapid and virtually complete recovery of systolic 
and diastolic intracellular Ca2 to pre-ischemic values. In 
contrast, in mutant PLN hearts with non-phosphorylatable 
sites, the recovery of contractility and intracellular Ca2 
transient was significantly lower than that of age-matched 
PLN-WT. The present results provided evidence indicating 
that the presence of PLN phosphorylation sites is crucial for 
cardiac performance under stress conditions, like the 
ischemic-reperfusion insult.
Previous studies from our laboratory demonstrated that 
phosphorylation of Thr17 of PLN transiently increased at the 
beginning of reperfusion in the mouse and rat heart. This 
phosphorylation appeared to be important for the mechan­
ical recovery after ischemia and is evoked by CaMKII 
activation at the beginning of reperfusion [6,7]. Moreover, 
transgenic mice lacking either phosphorylatable site of PLN 
showed an impaired mechanical recovery of the stunned 
heart [7]. It was hypothesized that the presence of these sites 
is necessary for Ca2 handling during myocardial recovery 
in the reperfusion period. Thus, their absence would induce 
a more important impairment of Ca2 transient and would 
enhance Ca2 overload, with two possible additional 
consequences: (1) a further decrease in Ca2+ myofibrillar 
responsiveness, which seems to be the hallmark of 
myocardial stunning in rodents [3,4]; and (2) an increase 
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in the propensity of the stunned heart to exhibit mechanical 
alterations and arrhythmias, typical of Ca2+ overload and 
Ca2+ mishandling [8,9]. The present results provided 
evidence supporting that phosphorylation of Thr17 of PLN 
occurs at the beginning of reperfusion by CaMKII activation 
and further indicate that PLN phosphorylation sites are 
essential for the recovery of diastolic Ca2+ and Ca2+ 
transient during stunning. In addition, although our findings 
failed to detect any significant difference in myofibrillar 
Ca2+ responsiveness and Tnl degradation, between PLN- 
WT and PLN-DM mice, they did show that the presence of 
PLN phosphorylation residues is important to reduce the 
periods of mechanical altemans, one of the consequences of 
Ca2+ overload.
4.1. Ca^ signaling recorded in the beating heart
In the present study, we used a novel technique that 
allows for simultaneous detection of intraventricular pres­
sure and Ca2+ transient at the cellular level but recorded in 
the beating heart. The measurement of Ca2+ signals when the 
cells are in their natural environment gives important 
information of the organ function [18,19]. Recordings in 
the intact beating heart have typically utilized fluorescence 
spectroscopy [19], but an obstacle, associated with fluores­
cence approaches, is motion artifacts generated by cardiac 
contraction. To minimize the effects of contractile motion on 
the fluorescence signal, these studies have been previously 
conducted on mechanically [18,20] or chemically immobi­
lized hearts [21]. In any case, “motion-free” signals are then 
detected with bi-dimensional sensors [20]. Moreover, in these 
studies, large working distances of the optic limit the spatial 
resolution. To overcome this problem, optical fibers have 
been used to conduct epifluorescence measurements [22]. In 
the present study, we presented a novel way to improve the 
signal to noise ratio, by combining the pulsed-local field 
fluorescence illumination with an integrating current to 
voltage conversion, with a digital evaluation of the integrated 
photocurrent. This methodology, based on the technique 
presented by Mejia-Alvarez et al. [10], has both an improved 
signal to noise ratio and a diminished photobleaching effect. 
One limitation of this technique is that myoplasmic Ca2+ can 
only be assessed at the epicardium. Differences in Ca2+ 
transients between epicardium and endocardium may arise 
from the ventricular transmural dispersion of the mechanisms 
underlying excitation-contraction coupling [23]. This issue 
requires further research.
Since myoglobin (Mb) strongly absorbs light depending 
on tissue oxygenation, at 540 and 580 nm (oxy-Mb) and 550 
nm (deoxy-Mb) [24], it could be argued that this may affect 
the Rhod-2-Ca2+ measurements. This possibility seems 
unlikely however, since similar results were obtained in 
ischemia/reperfusion experiments in which the hearts were 
simultaneously loaded with Rhod-2 (excited at 532 nm) and 
Fluo-4 (excited at 452 nm). These experiments indicate that 
the changes of the Rhod-2 fluorescent signal observed in our 
experiments reflect actual variations of Ca2+ occurring 
during ischemia/reperfusion.
The results indicated that reperfusion causes an initial 
dramatic increase in diastolic Ca2+ that gradually returned to 
pre-ischemic levels after 10 min of reperfusion in PLN-WT 
hearts. Ca2+ transient amplitude, that was initially de­
pressed, also returned towards pre-ischemic values by the 
end of the reperfusion period. In agreement with previous 
results, this study indicates that in hearts from PLN-WT 
mice, the availability of activator Ca2+ is not the primary 
cause of the contractile dysfunction of the stunned heart, at 
least in rodents [3,4]. In contrast, in PLN-DM hearts, 
diastolic Ca2+ remained at levels significantly higher than 
pre-ischemic values over all the reperfusion period and 
intracellular Ca2+ transients are far from complete recovery 
at the end of the reperfusion period. The elevated diastolic 
intracellular Ca2+ in PLN-DM hearts would be the result of 
less Ca2+ being reuptaken by the SR because of the lack of 
PLN phosphorylation sites. As a consequence, Ca2+ 
released by the SR is less and therefore Ca2+ transient 
amplitude in PLN-DM is significantly lower with respect to 
PLN-WT mice. These results indicate that the decrease in 
intracellular Ca2+ transient is a main component in the 
contractile alteration of the stunned PLN-DM heart.
4.2. Myofibrillar Ca2+ responsiveness
After 30 min of reperfusion, myocardial contractility was 
significantly lower in PLN-WT hearts. In contrast, intracel­
lular Ca2+ transients decreased only slightly, although 
significantly, at the end of reperfusion, and diastolic Ca2+ 
completely returned to pre-ischemic levels. These findings 
indicate that myocardial stunning in mice is primarily 
dependent on a decrease in Ca2+ myofibrillar responsive­
ness, with a minor contribution of intracellular Ca2+, in 
agreement with previous results obtained in rat, guinea pigs 
and ferret hearts [3,4,16]. Among the possible mechanisms 
involved in the decrease of Ca2+ myofibrillar responsiveness 
is a Ca2+-induced proteolytic degradation of contractile 
proteins [2]. We hypothesized that, if this were the case, the 
decrease in myofibrillar Ca2+ responsiveness might be more 
important in PLN-DM than in PLN-WT mice, due to the 
persistent increase in diastolic Ca2+ present in PLN-DM 
hearts during reperfusion. However, our results failed to 
detect any significant difference in myofibrillar Ca2+ 
responsiveness between the two groups. Moreover, Tnl 
degradation was also similar in both groups of hearts. These 
results might indicate that the increase in Ca2+ overload in 
PLN-DM hearts was not sufficiently enhanced relative to 
that in PLN-WT hearts to produce a further decrease in 
myofibrillar Ca2+ responsiveness or to evoke a degradation 
of Tnl, that could not be detected in mice with intact PLN. 
Interestingly, the results allowed dissociation between the 
decrease in Ca2+ myofilament sensitivity, observed in the 
stunned hearts of both groups, from the degradation of Tnl, 
which did not occur in either group. Thus, other mecha­
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nisms, different from or in addition to intracellular Ca2+ 
overload, are playing a major role in the decrease in 
myofilament Ca2+ responsiveness typical of the stunned 
heart in rodents [2]. Additional proposed mechanisms are 
alteration of myofibrillar proteins different from Tnl, 
induced by the production of oxygen-free radicals [2], the 
persistent elevation of intracellular magnesium [25] or even 
intracellular edema. Obviously, more work is needed to 
support these possibilities.
4.3. Mechanical alternons and Ca^ mishandling
Mechanical altemans represents an abnormality of Ca2+ 
handling where large and small contractions follow each 
other due to alternation in systolic Ca2+. Altemans is not 
only prominent in heart failli re, but is also induced by 
ischemia and acidosis [9]. In our experimental conditions, 
both groups of hearts showed the same propensity to 
mechanical altemans. However, once installed, they per­
sisted for longer periods in PLN-DM than in PLN-WT 
hearts (Fig. 6). Mechanical altemans have been associated 
with alternations in the amount of Ca2+ release from the SR, 
due to a beat-to-beat change in either SR Ca2+ content or the 
properties of the Ca2+ release process [26]. Although we did 
not explore the issue, it is reasonable to speculate that the 
chronic inhibition of SERCA2a in PLN-DM hearts due to 
the lack of PLN phosphorylation residues is at the basis of 
the tendency of these hearts to perpetuate the cycle of 
mechanical altemans, once they started. This propensity of 
PLN-DM hearts to perpetuate the periods of mechanical 
abnormalities, coupled with the prominent and persistent 
increase in diastolic Ca2+ and diastolic tone, indicates that 
these hearts are less tolerant to Ca2+ loading than PLN-WT 
hearts. Our results indicate that the phosphorylation of 
Thr17, at the onset of reperfusion, only present in PLN-WT 
hearts, is a crucial factor in the subsequent recovery of Ca2+ 
handling and mechanical performance of the stunned heart. 
The impairment of Ca2+ recovery in the transgenic animals, 
lacking PLN phosphorylation sites, highlight the role of 
PLN residues, when they are on site. The important role of 
PLN phosphorylation dining the critical early phase of 
reperfusion was recently emphasized in a cellular model of 
ischemia/reperfusion injury [27]. The experiments indicated 
that cGMP-dependent phosphorylation of Ser16 of PLN is 
protective against reoxygenation injury in isolated myo­
cytes. The increase in SERCA2a activity due to PLN 
phosphorylation would support an early clearing of excess 
Ca2+ from the cytosol, favoring Ca2+ cycling and reducing 
oscillatory Ca2+ rise. This would in turn reduce cardiomyo­
cyte hypercontracture, at the beginning of reperfusion. 
Previous results from our own laboratory indicated that 
phosphorylation of Thr17 of PLN occurs as a consequence 
of the increase in cytosolic Ca2+ triggered by reperfusion 
[6]. The present findings also showed that this phosphor­
ylation precedes the recovery of intracellular Ca2+ in PLN- 
WT hearts. This recovery did not occur in animals lacking 
phosphorylatable sites in PLN. Taken together, the results 
emphasize the importance of PLN as a target for new 
strategies of cardioprotection against ischemia/reperfusion 
injury in the clinical setting.
In summary, our results indicate for the first time that the 
presence of PLN phosphorylation sites are crucial for the 
mechanical and intracellular Ca2+ recovery in the stunned 
heart and are protective against the propensity to mechanical 
abnormalities that occurred during stunning. These results, 
together with the fact that phosphorylation of Ser16 of PLN 
by cGMP has been also shown to be protective in ischemia/ 
reperfusion injury [27], shed new lights for the search of 
novel strategies for cardioprotection in the clinical setting. 
Finally, the present findings also emphasize that although 
the absence of PLN phosphorylation sites seems not to 
affect basal contractility, it does alter the handling of Ca2+ 
and the mechanical performance of the heart under stress 
situations.
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